EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Financial Comparison: Novavax (NASDAQ:NVAX) and Beam Therapeutics (NASDAQ:BEAM) - Zolmax
Head-To-Head Contrast: Beam Therapeutics (NASDAQ:BEAM) & Novavax (NASDAQ:NVAX)
What Novavax Doubters Overlooked
Is Novavax (NVAX) Fully Priced Relative To Its Sales Base?
Novavax (NASDAQ:NVAX) Stock Falls 12.9% - Time to Sell?
3 Reasons NVAX is Risky and 1 Stock to Buy Instead
Novavax Plunges 12% as Selloff Hits Vaccine Makers; Moderna Tumbles 10%, Pfizer Holds Steady
Novavax (NASDAQ:NVAX) Shares Down 9.1% - Should You Sell?
Taiwan CDC to procure nearly 500,000 more flu, COVID-19 vaccine doses - Focus Taiwan
Head-To-Head Review: Novavax (NASDAQ:NVAX) & Alnylam Pharmaceuticals (NASDAQ:ALNY)
Novavax Soars 16%, Moderna Surges 11%, Merck Climbs 3% as Biotech Rallies
Novavax, Inc. $NVAX Position Lowered by Shah Capital Management - Zolmax
Novavax, Inc. $NVAX Stock Holdings Lessened by Shah Capital Management - Markets Daily
Novavax (NASDAQ:NVAX) Sees Strong Trading Volume - Should You Buy?
Novavax (NASDAQ:NVAX) Sees Large Volume Increase - Should You Buy? - Daily Political
Novavax (NVAX) Stock Could Be Above Fair Value As Plague Fears Fade
Novavax (NASDAQ:NVAX) Sets New 12-Month High - Here's What Happened - Markets Daily
Novavax Pulls Back From Plague-Scare Spike as Officials Call Risk Low; Moderna Nudges Higher, Pfizer Inches Higher
Novavax (NASDAQ:NVAX) Reaches New 1-Year High - Time to Buy?
NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'
NVAX Stock Outruns Moderna As Vaxcyte's Shot Clears A Late-Stage Test
Investors Purchase Large Volume of Novavax Call Options (NASDAQ:NVAX)
Novavax Soars 22% as Sanofi Carries Nuvaxovid Into Vaccination Season; Moderna Climbs 8%, BioNTech Ticks Up
Novavax (NASDAQ:NVAX) Shares Up 10.5% - Here's Why
Novavax (NASDAQ:NVAX) Stock Jumps 10.5% - Still a Buy? - Daily Political
Novavax, Inc. (NASDAQ:NVAX) Stock Has Average Price Target of $14.00 According to Brokerages
Novavax (NASDAQ:NVAX) Stock Crosses Above 200 Day Moving Average - What's Next?
